Strategic Growth
Pathology Business Development
Strategic growth in the pathology sector relies on identifying the right partners, understanding shifting reimbursement landscapes, and structuring models that create mutual clinical and economic value.
Who this service helps
- Independent reference laboratories seeking new revenue streams
- Diagnostic companies looking for channel partners
- Health systems evaluating joint ventures or outreach expansion
- Technology vendors needing integration partnerships
What the work can accomplish
- Identified and vetted strategic partnership targets
- Structured joint venture and commercial alliance frameworks
- Expansion strategies for new subspecialty test menus
- Competitive positioning for hospital outreach programs
How we approach it
- We evaluate your current market position and operational capabilities to find logical expansion vectors.
- We identify partnership opportunities that bridge technology, test menu, or geographic gaps.
- We model the economics of potential partnerships, ensuring aligned incentives.
- We assist in structuring agreements that protect laboratory independence while driving volume.
Experienced pathology leadership
David “DJ” Dalton, PhD, MBA brings more than 20 years of pathology industry experience spanning Labcorp, Paige AI, Lumea/Modella AI, digital pathology, laboratory operations, product strategy, commercialization, and executive leadership.
Last reviewed September 2026. About David Dalton
Frequently asked questions
How can an independent lab compete with national reference labs?
By focusing on turnaround time, subspecialty expertise, and superior client service. We help regional labs build business development strategies that highlight local accessibility and specialized consultative support.
What makes a successful pathology partnership?
Successful partnerships align clinical quality with financial incentives. Whether it's a tech vendor integrating with an LIS or two labs sharing capacity, the arrangement must clearly reduce friction or create net-new revenue for both parties.
How do we enter a new pathology subspecialty market?
Entering a new market requires acquiring or partnering for subspecialty sign-out expertise, validating the necessary assays, and building a targeted sales strategy for those specific ordering physicians.